Central nervous system pharmacokinetics of high-dose cytosine arabinoside

Clinical pharmacology of l‐β‐D‐arabinofuranosyl cytosine

1971 • 317 citations

High dose cytosine arabinoside (HDARAC) in refractory acute leukemia

1979 • 290 citations

Central nervous system toxicity of high-dose systemic cytosine arabinoside

1981 • 204 citations

Chemotherapy of Brain Tumors

1977 • 196 citations

A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.

1982 • 191 citations

Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid.

1983 • 146 citations

Alteration of the pharmacokinetics of high-dose ara-C by its metabolite, high ara-U in patients with acute leukemia.

1983 • 124 citations

Pharmacokinetics and metabolism of cytosine arabinoside in the central nervous system.

1982 • 114 citations

Clinical results and pharmacokinetics of high-dose cytosine arabinoside (HD ARA-C)

1982 • 78 citations

Effects of high-dose cytarabine

1982 • 68 citations

Drugs Five Years Later

1975 • 61 citations

Pharmacokinetics of continuous intravenous and subcutaneous infusions of cytosine arabinoside

1982 • 57 citations

Simple and rapid high-performance liquid chromatographic method for analysis of nucleosides in biological fluids

1982 • 39 citations

Cerebrospinal fluid and plasma pharmacokinetics of high doses of 1-beta-D-arabinofuranosylcytosine in nonhuman primates.

1983 • 7 citations